TMCLIFE 0101 Share Price
RM0.45
klse: TMC Life Sciences Berhad
Stock Information
Board : Main
Shariah : Non-Shariah Compliant
Sector : Hospital or Centre
Address: 10th Floor, Menara Hap Seng, No. 1 & 3, Jalan P. Ramlee, 50250, Kuala Lumpur
Contact: +603-23824288
Website: https://www.tmclife.com/
Stock Background
TMC Life Sciences Berhad provides health care services. The Company offers human infertility consulting and treatment services.
Profit Analysis: TMCLIFE 0101
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 20/05/26 | 89,701 | 2,749 | 1,758 |
| 09/02/26 | 103,497 | 9,336 | 6,560 |
| 21/11/25 | 100,477 | 6,567 | 4,413 |
| 26/08/25 | 93,273 | 3,054 | 2,423 |
| 21/05/25 | 89,872 | 52 | -806 |
| 10/02/25 | 80,426 | -493 | -947 |
| 18/11/24 | 81,967 | 4,459 | 2,936 |
| 21/08/24 | 74,124 | 341 | 1,024 |
| 23/05/24 | 86,073 | 12,457 | 9,960 |
| 02/02/24 | 93,783 | 19,680 | 14,524 |
| 14/11/23 | 92,438 | 20,143 | 15,140 |
| 22/08/23 | 84,652 | 12,585 | 13,245 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 387 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | 15,154 |
| Last 4 Quarter EPS (sen) | 0.87 |
| Last 4 Quarter PER | 51.73 |
| Last 4 Quarter Dividend (sen) | 19.00 |
| Last 4 Quarter Dividend Yield (%) | 0.42 |
| Net Tangible Assets (RM) | 4900.00 |
| Goodwill (RM) | 196,840 |
| Cash (RM’000) | 118,120 |
| Debt (RM’000) | 156,150 |
| Total Debt (RM’000) | 247,470 |
| Net Assets (RM’000) | 862,530 |
| Current Ratio | 1.84 |
| Quick Ratio | 1.69 |
| Cash Ratio | 0.99 |
Technical
Technical Analysis
| MACD (26 vs 12) | -4.773 |
|---|---|
| Exponential Moving Average 5 | 0.456 |
| Exponential Moving Average 20 | 0.444 |
| Exponential Moving Average 90 | 0.476 |
| Relative Strength Index 14 | 0.40 |
| Stochastic %D 3 | 0.33 |
| Stochastic %K 14 | 0.67 |
17 reviews for TMCLIFE 0101
Show all Most Helpful Highest Rating Lowest Rating
Only logged in customers who have purchased this product may leave a review.
Stock Profit Analysis
-
BNASTRA 7195 ★★★★★RM2.14 - PETRONM 3042 ★★★★★RM3.44
- CMSB 2852 ★★★★★RM1.00
- SUNREIT 5176 ★★★★★RM2.23
Salary Proof
BURSA MALAYSIA –
For the financial year ended 30 June 2024, the Group recorded 11% increase in revenue to RM346.4 million and profit before taxation increased by 29% to RM52.6 million compared to the same period ended 30 June 2023. The increase in revenue and profit before taxation was attributed to the increased capacity at Thomson Hospital Kota Damansara, a rebound in the fertility business, and higher interest income. Moving forward, The Group is closely monitoring the evolving global economic landscape, interest rate risk, and is committed to adapt its business strategy to mitigate any adverse impact to the Group’s performance. Increased capacity in THKD and rebound of fertility business are expected to drive growth. Additionally, the Group is focusing on diversifying customer base including international market expansion.
BURSA MALAYSIA –
Compared with the immediate preceding quarter ended 30 September 2022, revenue increased by 2%, however, profit before taxation decreased by 12%. Higher revenue was contributed by the increase in hospital revenue while decrease in profit before taxation was due to higher staff costs and interest expense. Hospital and fertility recorded revenue of RM64.3 million and RM8.6 million for quarter ended 31 December 2022 compared to
RM62.8 million and RM8.7 million recorded in the immediate preceding quarter, respectively
BURSA MALAYSIA –
Compared with the immediate preceding quarter ended 30 June 2022, profit before taxation decreased by 16% mainly due to higher staff cost and interest expense.